Leoni Mollie

Insider profile

Performance

Overall performance
3.1

Performance over holding periods
3.1
30 days 90 days 120 days
Average return -2% 8.2% 15.1%
Success rate 41% 68% 82%
Transactions
11 0% Buy
34 71% Buy
47 69% Buy
Leoni Mollie's trades of Kura Oncology, Inc.'s stock


Loading...
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Planned sale
Price
409.58
Quantity 36,701 +26.6%
Value US$1,273,387
Transaction date
Proposed sale
Price
270.07
Quantity 7,831
Value US$1,002,121
Transaction date
Sale
Price
366.57
Quantity 41,333 +20.2%
Value US$3,323,733
Transaction date
Proposed sale
Price
10.76
Quantity 12,448
Value US$133,940
Transaction date
Planned sale
Price
9.82
Quantity 84,929 -31.8%
Value US$834,283
Transaction date
Planned sale
Price
9.82
Quantity 84,929 -31.8%
Value US$834,283
Transaction date
Proposed sale
Price
9.57
Quantity 84,929
Value US$812,771
Transaction date
Proposed sale
Price
8.47
Quantity 8,180
Value US$69,285
Transaction date
Proposed sale
Price
10.68
Quantity 15,485
Value US$165,380
Transaction date
Sale
Price
11.18
Quantity 15,485 -6.4%
Value US$173,074
Transaction date
Proposed sale
Price
9.05
Quantity 12,314
Value US$111,442
Transaction date
Sale
Price
8.94
Quantity 12,314 -7.2%
Value US$110,114
Transaction date
Proposed sale
Price
7.77
Quantity 4,963
Value US$38,563
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2026-09-29 2026-09-29 PlS Planned sale
36,701 +26.6%
409.58
US$1,273,387
36,701 +26.6% 409.58 US$1,273,387
2026-09-29 2026-09-29 PrS Proposed sale
7,831
270.07
US$1,002,121
7,831 270.07 US$1,002,121
2026-09-29 2026-09-28 S Sale
41,333 +20.2%
366.57
US$3,323,733
41,333 +20.2% 366.57 US$3,323,733
2026-09-28 2026-09-28 PrS Proposed sale
12,448
10.76
US$133,940
12,448 10.76 US$133,940
2026-06-22 2026-06-18 PlS Planned sale
84,929 -31.8%
9.82
US$834,283
84,929 -31.8% 9.82 US$834,283
2026-06-22 2026-06-18 PlS Planned sale
84,929 -31.8%
9.82
US$834,283
84,929 -31.8% 9.82 US$834,283
2026-06-18 2026-06-18 PrS Proposed sale
84,929
9.57
US$812,771
84,929 9.57 US$812,771
2026-01-27 2026-01-27 PrS Proposed sale
8,180
8.47
US$69,285
8,180 8.47 US$69,285
2026-01-27 2026-01-27 S Sale
1,341 -0.5%
8.46
US$11,346
1,341 -0.5% 8.46 US$11,346
2026-01-27 2026-01-27 S Sale
951 -0.4%
8.46
US$8,046
951 -0.4% 8.46 US$8,046
2026-01-27 2026-01-27 S Sale
2,233 -0.8%
8.46
US$18,893
2,233 -0.8% 8.46 US$18,893
2026-01-27 2026-01-27 S Sale
3,655 -1.3%
8.46
US$30,924
3,655 -1.3% 8.46 US$30,924
2025-11-14 2025-11-14 PrS Proposed sale
15,485
10.68
US$165,380
15,485 10.68 US$165,380
2025-11-14 2025-11-14 S Sale
15,485 -6.4%
11.18
US$173,074
15,485 -6.4% 11.18 US$173,074
2025-09-29 2025-09-29 PrS Proposed sale
12,314
9.05
US$111,442
12,314 9.05 US$111,442
2025-09-29 2025-09-29 S Sale
12,314 -7.2%
8.94
US$110,114
12,314 -7.2% 8.94 US$110,114
2025-01-28 2025-01-28 PrS Proposed sale
4,963
7.77
US$38,563
4,963 7.77 US$38,563
2025-01-28 2025-01-28 S Sale
541 -0.6%
7.87
US$4,259
541 -0.6% 7.87 US$4,259
2025-01-28 2025-01-28 S Sale
816 -0.9%
7.87
US$6,423
816 -0.9% 7.87 US$6,423
2025-01-28 2025-01-28 S Sale
1,353 -1.5%
7.87
US$10,651
1,353 -1.5% 7.87 US$10,651
2025-01-28 2025-01-28 S Sale
2,253 -2.4%
7.87
US$17,735
2,253 -2.4% 7.87 US$17,735